Bio-Rad Laboratories ddPCR Microsatellite Instability (MSI) Assay

Friday, 19 July, 2019 | Supplied by: Bio-Rad Laboratories Pty Ltd


Bio-Rad’s ddPCR Microsatellite Instability (MSI) Assay can be completed in one day on a ddPCR-based platform to quantify the level of MSI present in colorectal tumours.

Using either a blood or FFPE sample, the RUO assay quantitatively identifies mutations in five loci that lead to identification of MSI status. Colorectal tumours that test positive for MSI-high are candidates for treatment with immune-checkpoint inhibitors.

Simple and sensitive, the assay provides a standardised output that does not require a pathologist’s interpretation. The test can use patient blood samples in the absence of tumour tissue and does not require matched normal tissue or normal blood samples.

Online: www.bio-rad.com
Phone: 02 9914 2800
Related Products

Navinci Diagnostics NaveniFlex Cell Red proximity ligation assay kit

Optimised for cell samples, the kit enables fluorescence visualisation of protein–protein...

Lonza TheraPEAK AmpliCell Cytokines and TheraPEAK 293-GT Medium

The products provide researchers and manufacturers with high-performance, scalable and...

Grace Bio-Labs protein microarray tools

Grace Bio-Labs' microarray substrates provide high binding capacity and enable high assay...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd